<- Go Home
Greenland Mines Ltd
Greenland Mines Ltd operates as a natural resources company. It focuses on the exploration and development of Skaergaard Project in Southeast Greenland. The company is also involved in the development of KLTO-202, a cell and gene therapy for amyotrophic lateral sclerosis. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Market Cap
$60.1M
Volume
11.6M
Cash and Equivalents
$7.2M
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$3.91
52 Week Low
$0.12
Dividend
N/A
Price / Book Value
3.80
Price / Earnings
-2.28
Price / Tangible Book Value
5.02
Enterprise Value
$52.9M
Enterprise Value / EBITDA
N/A
Operating Income
-$7.1M
Return on Equity
198.18%
Return on Assets
-74.13
Cash and Short Term Investments
$7.2M
Debt
N/A
Equity
$9.5M
Revenue
N/A
Unlevered FCF
-$3.9M
Sector
Biotechnology
Category
N/A